ZA9811068B - Solution-phase site-specific preparation of GRF-PEG conjugates - Google Patents
Solution-phase site-specific preparation of GRF-PEG conjugatesInfo
- Publication number
- ZA9811068B ZA9811068B ZA9811068A ZA9811068A ZA9811068B ZA 9811068 B ZA9811068 B ZA 9811068B ZA 9811068 A ZA9811068 A ZA 9811068A ZA 9811068 A ZA9811068 A ZA 9811068A ZA 9811068 B ZA9811068 B ZA 9811068B
- Authority
- ZA
- South Africa
- Prior art keywords
- grf
- solution
- specific preparation
- peg conjugates
- phase site
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97121264A EP0922446A1 (fr) | 1997-12-03 | 1997-12-03 | Préparation des conjugués du GRF-PEG par un méthode en solution spécifique à un site |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9811068B true ZA9811068B (en) | 1999-06-28 |
Family
ID=8227732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9811068A ZA9811068B (en) | 1997-12-03 | 1998-12-03 | Solution-phase site-specific preparation of GRF-PEG conjugates |
Country Status (30)
| Country | Link |
|---|---|
| US (3) | US6528485B1 (fr) |
| EP (2) | EP0922446A1 (fr) |
| JP (2) | JP2001524505A (fr) |
| KR (1) | KR100561768B1 (fr) |
| CN (1) | CN1149967C (fr) |
| AR (1) | AR017780A1 (fr) |
| AT (1) | ATE236607T1 (fr) |
| AU (1) | AU755285B2 (fr) |
| BG (1) | BG64815B1 (fr) |
| BR (1) | BR9815159A (fr) |
| CA (1) | CA2312004C (fr) |
| DE (1) | DE69813291T2 (fr) |
| DK (1) | DK1037587T3 (fr) |
| EA (1) | EA004269B1 (fr) |
| EE (1) | EE200000319A (fr) |
| ES (1) | ES2194376T3 (fr) |
| HK (1) | HK1034203A1 (fr) |
| HU (1) | HUP0100507A3 (fr) |
| IL (2) | IL136551A0 (fr) |
| NO (1) | NO327238B1 (fr) |
| NZ (1) | NZ504570A (fr) |
| PL (1) | PL192082B1 (fr) |
| PT (1) | PT1037587E (fr) |
| SI (1) | SI1037587T1 (fr) |
| SK (1) | SK8242000A3 (fr) |
| TR (1) | TR200001615T2 (fr) |
| TW (1) | TWI254641B (fr) |
| UA (1) | UA73716C2 (fr) |
| WO (1) | WO1999027897A1 (fr) |
| ZA (1) | ZA9811068B (fr) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010055581A1 (en) | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
| US7229841B2 (en) * | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
| US6407218B1 (en) * | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
| WO2002028437A1 (fr) * | 2000-10-05 | 2002-04-11 | Ares Trading S.A. | Pegylation stereoselective en phase liquide |
| EP1234583A1 (fr) * | 2001-02-23 | 2002-08-28 | F. Hoffmann-La Roche Ag | Conjugués du PEG et du HGF-NK4 |
| US20030171285A1 (en) * | 2001-11-20 | 2003-09-11 | Finn Rory F. | Chemically-modified human growth hormone conjugates |
| US8048408B2 (en) * | 2002-01-16 | 2011-11-01 | Biocompatibles Uk Limited | Polymer conjugates |
| US7998705B2 (en) * | 2002-08-06 | 2011-08-16 | FUJIFILM Diosynth Biotechnologies U.S.A., Inc | Increased dynamic binding capacity in ion exchange chromatography by addition of polyethylene glycol |
| CN1688696A (zh) * | 2002-09-18 | 2005-10-26 | 蒙特利尔大学医疗中心 | Ghrh类似物 |
| GB0301014D0 (en) * | 2003-01-16 | 2003-02-19 | Biocompatibles Ltd | Conjugation reactions |
| CN100357313C (zh) * | 2003-01-18 | 2007-12-26 | 派格斯菲尔有限公司 | 非靶位点胺基被保护的肽,其制备方法以及使用该肽制备特异性地结合的peg肽的方法 |
| AU2004259727A1 (en) * | 2003-07-15 | 2005-02-03 | Barros Research Institute | Compositions and methods for immunotherapy of cancer and infectious diseases. |
| WO2005010163A2 (fr) * | 2003-07-15 | 2005-02-03 | Barros Research Institute | Compositions et procedes d'immunotherapie contre le virus de l'immunodeficience humaine (vih) |
| CA2548179A1 (fr) * | 2003-12-02 | 2005-07-21 | Cytimmune Sciences, Inc. | Procedes et compositions de production d'anticorps monoclonaux |
| CN1960825A (zh) * | 2004-01-28 | 2007-05-09 | 细胞免疫科学公司 | 官能化胶态金属组合物和方法 |
| CN100355784C (zh) * | 2004-02-12 | 2007-12-19 | 江苏恒瑞医药股份有限公司 | 聚乙二醇修饰α－干扰素1b的制备方法 |
| US20050261475A1 (en) * | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
| US6986264B1 (en) * | 2004-07-15 | 2006-01-17 | Carrier Corporation | Economized dehumidification system |
| NO20210454A1 (no) | 2004-11-12 | 2007-06-27 | Bayer Healthcare Llc | Setedirigert modifikasjon av FVIII |
| WO2007016105A2 (fr) * | 2005-07-26 | 2007-02-08 | Rhodia Inc. | Polymeres ayant des groupes substituants de poly(alkyleneoxy) pendants et leur utilisation dans des applications de soins d'hygiene personnelle |
| US20070238656A1 (en) * | 2006-04-10 | 2007-10-11 | Eastman Kodak Company | Functionalized poly(ethylene glycol) |
| CA2653748A1 (fr) | 2006-05-02 | 2007-11-15 | Allozyne, Inc. | Polypeptides substitues par des acides amines non naturels |
| US20080096819A1 (en) * | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
| US8765924B2 (en) * | 2006-08-04 | 2014-07-01 | Prolong Pharmaceuticals, Inc. | Modified erythropoietin |
| US20080083154A1 (en) * | 2006-10-05 | 2008-04-10 | Timothy M Gregory | Bait retention fish hook |
| CA2707840A1 (fr) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Molecules substituees par des acides amines |
| US20110014118A1 (en) * | 2007-09-21 | 2011-01-20 | Lawrence Tamarkin | Nanotherapeutic colloidal metal compositions and methods |
| JP2011520769A (ja) * | 2007-09-21 | 2011-07-21 | サイトイミューン サイエンシズ インコーポレイテッド | ナノ治療コロイド金属組成物および方法 |
| EP2219458B1 (fr) | 2007-11-08 | 2015-07-15 | Cytimmune Sciences, Inc. | Compositions et procédés de production d'anticorps |
| EP2362881B1 (fr) * | 2008-11-04 | 2019-03-13 | Janssen Pharmaceutica NV | Agonistes peptidiques du récepteur d'hormone de libération de la corticotropine de type 2 (crhr2) et leurs utilisations |
| RU2495881C2 (ru) * | 2009-03-20 | 2013-10-20 | Ханми Холдингс Ко., Лтд. | Способ регулирования условий для сайт-специфического связывания полипептида и непептидильного полимера |
| US20100267635A1 (en) * | 2009-04-20 | 2010-10-21 | Theratechonolgies Inc. | Use of protease inhibitors and grf molecules in combination therapy |
| US20100267636A1 (en) * | 2009-04-20 | 2010-10-21 | Theratechnologies Inc. | Use of cytochrome p450-metabolized drugs and grf molecules in combination therapy |
| US10370245B2 (en) | 2009-06-22 | 2019-08-06 | Sanford-Burnham Medical Research Institute | Methods and compositions using peptides and proteins with C-terminal elements |
| JP2013510167A (ja) * | 2009-11-04 | 2013-03-21 | ヤンセン ファーマシューティカ エヌ．ベー． | ストレスコピン様ペプチドによる心不全の治療方法 |
| WO2012118778A1 (fr) | 2011-02-28 | 2012-09-07 | Sanford-Burnham Medical Research Institute | Peptides car tronqués, procédés et compositions les utilisant |
| CN103547591A (zh) | 2011-04-21 | 2014-01-29 | 瑟瑞技术公司 | 生长激素释放因子(grf)类似物及其用途 |
| WO2012166585A2 (fr) | 2011-05-31 | 2012-12-06 | Airware, Inc. | Réétalonnage de capteurs de gaz non dispersif à absorption dans l'infrarouge (ndir) sollicités par absorption |
| US10179801B2 (en) | 2011-08-26 | 2019-01-15 | Sanford-Burnham Medical Research Institute | Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides |
| WO2013190520A2 (fr) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Agents de libération de gh dans le traitement d'une sténose vasculaire et d'états associés |
| US10064940B2 (en) | 2013-12-11 | 2018-09-04 | Siva Therapeutics Inc. | Multifunctional radiation delivery apparatus and method |
| CA2986927C (fr) | 2015-05-28 | 2023-12-19 | Institut National De La Recherche Scientifique | Inhibiteurs de la dimerisation de galectines prototypiques et leur utilisation |
| HUE052802T2 (hu) | 2016-04-19 | 2021-05-28 | Griffon Pharmaceuticals Int Sa | Pegilezett bioaktív peptidek és alkalmazásaik |
| CN110317826B (zh) * | 2019-05-22 | 2020-11-10 | 中国农业大学 | 调控PvGRF9含量或活性的物质在调控植物茎生长发育中的应用 |
| WO2021133407A1 (fr) | 2019-12-27 | 2021-07-01 | Compagnie Generale Des Etablissements Michelin | Mélange de caoutchouc à noir d'acétylène de surface spécifique élevée et de structure élevée |
| EP4284828A1 (fr) | 2021-01-28 | 2023-12-06 | Talem Therapeutics LLC | Anticorps anti-glycoprotéine anti-spicule de sars-cov-2 et leur utilisation thérapeutique |
| WO2024081918A1 (fr) | 2022-10-14 | 2024-04-18 | Talem Therapeutics Llc | Anticorps anti-trkb/cd3 et leurs utilisations |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4563352A (en) * | 1982-10-04 | 1986-01-07 | The Salk Institute For Biological Studies | Human pancreatic GRF |
| DK0400472T3 (da) * | 1989-05-27 | 1996-05-13 | Sumitomo Pharma | Fremgangsmåde til fremstilling af polyethylenglycolderivater og modificeret protein |
| EP0544706A4 (en) * | 1990-06-29 | 1993-10-13 | Hoffmann-La Roche Inc. | Histidine substituted growth hormone releasing factor analogs |
| JP3051145B2 (ja) * | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
| WO1992018531A1 (fr) * | 1991-04-09 | 1992-10-29 | F. Hoffmann-La Roche Ag | Analogues de somatocrinine |
| EP0518295A3 (en) * | 1991-06-14 | 1993-09-01 | Millipore Corporation | Allyl side chain protection in peptide synthesis |
| FR2687681B1 (fr) * | 1992-02-20 | 1995-10-13 | Transgene Sa | Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses. |
| US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| WO1997017367A1 (fr) * | 1995-11-03 | 1997-05-15 | Theratechnologies Inc. | Technique de synthese de peptides grf |
-
1997
- 1997-12-03 EP EP97121264A patent/EP0922446A1/fr not_active Withdrawn
-
1998
- 1998-01-12 UA UA2000063885A patent/UA73716C2/uk unknown
- 1998-12-01 PT PT98959898T patent/PT1037587E/pt unknown
- 1998-12-01 TR TR2000/01615T patent/TR200001615T2/xx unknown
- 1998-12-01 IL IL13655198A patent/IL136551A0/xx unknown
- 1998-12-01 SI SI9830400T patent/SI1037587T1/xx unknown
- 1998-12-01 ES ES98959898T patent/ES2194376T3/es not_active Expired - Lifetime
- 1998-12-01 HU HU0100507A patent/HUP0100507A3/hu unknown
- 1998-12-01 EP EP98959898A patent/EP1037587B1/fr not_active Expired - Lifetime
- 1998-12-01 SK SK824-2000A patent/SK8242000A3/sk unknown
- 1998-12-01 CN CNB988117592A patent/CN1149967C/zh not_active Expired - Fee Related
- 1998-12-01 JP JP2000522885A patent/JP2001524505A/ja active Pending
- 1998-12-01 PL PL341139A patent/PL192082B1/pl not_active IP Right Cessation
- 1998-12-01 KR KR1020007005736A patent/KR100561768B1/ko not_active IP Right Cessation
- 1998-12-01 DK DK98959898T patent/DK1037587T3/da active
- 1998-12-01 AU AU15633/99A patent/AU755285B2/en not_active Expired
- 1998-12-01 CA CA002312004A patent/CA2312004C/fr not_active Expired - Lifetime
- 1998-12-01 DE DE69813291T patent/DE69813291T2/de not_active Expired - Lifetime
- 1998-12-01 BR BR9815159-2A patent/BR9815159A/pt not_active Application Discontinuation
- 1998-12-01 EE EEP200000319A patent/EE200000319A/xx unknown
- 1998-12-01 EA EA200000601A patent/EA004269B1/ru not_active IP Right Cessation
- 1998-12-01 AT AT98959898T patent/ATE236607T1/de active
- 1998-12-01 NZ NZ504570A patent/NZ504570A/en unknown
- 1998-12-01 WO PCT/EP1998/007748 patent/WO1999027897A1/fr active IP Right Grant
- 1998-12-02 AR ARP980106098A patent/AR017780A1/es active IP Right Grant
- 1998-12-03 ZA ZA9811068A patent/ZA9811068B/xx unknown
-
1999
- 1999-01-26 TW TW088101139A patent/TWI254641B/zh not_active IP Right Cessation
-
2000
- 2000-05-24 NO NO20002664A patent/NO327238B1/no not_active IP Right Cessation
- 2000-05-29 BG BG10448A patent/BG64815B1/bg unknown
- 2000-06-04 IL IL136551A patent/IL136551A/en not_active IP Right Cessation
- 2000-06-05 US US09/587,460 patent/US6528485B1/en not_active Expired - Lifetime
-
2001
- 2001-07-16 HK HK01104960A patent/HK1034203A1/xx not_active IP Right Cessation
-
2002
- 2002-11-20 US US10/299,790 patent/US6869932B2/en not_active Expired - Lifetime
-
2004
- 2004-12-15 US US11/011,617 patent/US7317002B2/en not_active Expired - Fee Related
-
2009
- 2009-10-30 JP JP2009251100A patent/JP5431874B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9811068B (en) | Solution-phase site-specific preparation of GRF-PEG conjugates | |
| GB9713980D0 (en) | New conjugates | |
| EP1020193A4 (fr) | Preparation orale | |
| GB9715751D0 (en) | Formulations | |
| PL340337A1 (en) | Drugs | |
| GB9713149D0 (en) | Pharmaceutical formulations | |
| GB9706089D0 (en) | Pharmaceutical composition | |
| PL335700A1 (en) | Novel preparation | |
| EP0978288A4 (fr) | Composition medicamenteuse | |
| PL337970A1 (en) | Novel preparation | |
| GB9717444D0 (en) | Pharmaceutical composition | |
| ZA982073B (en) | Pharmaceutical preparation | |
| HUP0002455A3 (en) | Gastric-retained pharmaceutical composition | |
| GB9717428D0 (en) | Pharmaceutical composition | |
| PL337722A1 (en) | Novel combination antiasthmatic drugs | |
| EP0973800A4 (fr) | Nouveau recepteur | |
| GB9717770D0 (en) | Pharmaceutical composition | |
| GB2321190B (en) | Pharmaceutical composition | |
| IL124387A0 (en) | Preparation of 5-Methyleneoxazolines | |
| GB2329384B (en) | Preparation of 1-chloro-1-cyclopropylethene | |
| GB9726781D0 (en) | Pharmaceutical composition | |
| GB9702652D0 (en) | Conjugates and their preparation | |
| PL322663A1 (en) | Dispergating preparation | |
| IL120319A0 (en) | Pharmaceutical preparation | |
| GB9722697D0 (en) | Experiment preparation unit |